AzTrials
AzTrials

StressNCT06243783

Impact of Stress on Brain Energy Metabolism

A study testing Montreal Imaging Stress Test in people with Stress, run by Rupert Lanzenberger at 1 site in Austria.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Background: Stress plays an essential role in the pathophysiology of mental disorders. However, individual differences in the vulnerability to acute and repeated stress are not well understood. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Stress
What is being tested?
Montreal Imaging Stress Test
Could I receive a placebo?
No, everyone receives an active treatment
How many people
68 participants
Where
1 siteAustria
Study dates
1 Mar 2024to 29 Feb 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18-40 years
  • right-handedness
  • willingness and competence to sign the informed consent form

Who cannot join

  • History of or current physical, neurological or psychiatric disorder
  • History of or current substance abuse or medication, including antipsychotic, antidepressant and antianxiety agents
  • Pregnancy of current breast-feeding
  • Contraindications for MRI-scanning (e.g., metal implants, steel grafts, etc.), including dental implants causing signal artifacts
  • For subjects participating in earlier studies using ionizing radiation, the total radiation exposure of 30 mSv over the last 10 years must not be exceeded, as specified in the Austrian legislation on radiation protection Accordingly, body weight > 105 kg is an exclusion criterion.
  • Failure to comply with the study protocol or to follow the instructions of the investigating team.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Austria1 site, 1 recruiting
  • Department of Psychiatry and Psychotherapy, Medical University of Vienna

    Vienna

    Rupert Lanzenberger, Prof, +43140400 ext. 35760, rupert.lanzenberger@meduniwien.ac.at

    Andreas Hahn, Assoc Prof

    Recruiting

Other trials in Austria

About this study

Official title: Impact of Acute Stress and Its Habituation on Brain Energy Metabolism

Background: Stress plays an essential role in the pathophysiology of mental disorders. However, individual differences in the vulnerability to acute and repeated stress are not well understood.

Aim: This work aims to investigate individual differences in glucose metabolism and directional connectivity regulating the neuronal stress response.

Read more

Design: 68 healthy volunteers will undergo two simultaneous PET/MRI measurements one week apart. Participants will complete the Montreal Imaging Stress Test during each measurement and in-between. Effects of stress on cognitive performance will be assessed using the n-back working memory task. Individual cortisol levels will be acquired to identify stress (non)responders as well as (non)habituators.

Implications: This work will characterize differences between stress responders vs. non-responders and stress habituators vs. non-habituators in terms of energy metabolism and network connectivity. This individual difference in the stress response may represent an important cornerstone for future evaluation of patients with mental disorders.

Read the detailed description

Methodological details: Each participant will undergo two PET/MRI scans. Imaging will include functional PET and as well as structural and functional MRI. Stress-specific glucose metabolism will be quantified with the radioligand [18F]FDG. Functional connectivity will be combined with glucose metabolism to assess directional connectivity. Based on previous literature, changes are expected to occur in the anterior cingulate cortex.

Conditions
Stress
Being tested
Montreal Imaging Stress Test

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Montreal Imaging Stress TestBehavioural

    In the Montreal Imaging Stress Test, participants are required to solve basic mathematical tasks, but the allowed reaction time is set lower than their average.

Study groups in NCT06243783
Study groupRoleWhat they receive
StressExperimentalMontreal Imaging Stress Test during each PET/MRI measurement and in-between
Receives: Behavioral: Montreal Imaging Stress Test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stress induced changes in glucose metabolism

    Glucose metabolism will be quantified from [18F]FDG PET imaging.

    Measured: 1 week

Secondary outcomes (2)
  1. Stress induced changes in directional connectivity

    Directional connectivity will be computed as combination of MRI-based functional connectivity and glucose metabolism.

    Measured: 1 week

  2. Stress induced changes in cognitive performance

    Cognitive performance will be obtained by the n-back working memory task.

    Measured: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2024
  2. Study start1 Mar 2024
  3. Primary completion29 Feb 2028 (estimated)
  4. Study completion29 Feb 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
68 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06243783
Sponsor's protocol ID
PSY-NIL-0012
Status last verified
Dec 2025
First submitted
29 Jan 2024
Last updated
23 Dec 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Anonymized data will be deposited on datadryad.

Questions about this trial

What is this clinical trial studying?

A study testing Montreal Imaging Stress Test in people with Stress, run by Rupert Lanzenberger at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Andreas Hahn, Assoc.Prof. (+43140400 ext. 23200, andreas.hahn@meduniwien.ac.at), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stress induced changes in glucose metabolism (time frame: 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in